The University of Southampton
University of Southampton Institutional Repository

Cysteinyl leukotriene involvement in chronic lung disease in premature infants

Cysteinyl leukotriene involvement in chronic lung disease in premature infants
Cysteinyl leukotriene involvement in chronic lung disease in premature infants

The pathopbysiology of chronic lung disease (CLD) in premature infants who require mechanical ventilation and prolonged oxygen supplementation has been well-described but the underlying mechanisms are not understood. Our aim was to test the hypothesis that excess cysteinyl leukotriene (LT) production was a contributing factor in CLD. We compared LT production and lung function, at 7 months of age, in nine premature infants with CLD and in eight control infants without CLD. None of the control infants developed any neonatal respiratory problems, but two subsequently required bronchodilator therapy. Respiratory function was assessed by the measurement of thoracic gas volume (TGV), airways resistance (Raw) and functional residual capacity (FRC). Total cysteinyl LT production was quantified by measurement of leukotriene E4 (LTE4) in a spot urine sample. Although all patients were asymptomatic at follow-up, there was evidence of significant lung function abnormalities in infants with CLD. The CLD infants had significantly elevated TGV, Raw and FRC values reflecting airway obstruction when compared to the controls. Urinary LTE4 levels were significantly higher in the CLD infants when compared to the controls (geometric mean: 741 and 337 pmol · mmol-1 creatinine, respectively). There was no direct correlation between urinary LTE4 levels in the CLD group and TGV, Raw or FRC values. Although this study is small and a direct correlation between lung function and urinary leukotriene E4 was not demonstrated, pathological lung function and an enhanced urinary leukotriene E4 production in infants with chronic lung disease would tend to suggest that the cysteinyl leukotrienes were involved in the sequelae of this disease.

Chronic lung disease, Lung function, Prematurity, Urinary leukotriene E
0903-1936
1907-1912
Cook, A. J.
44a62c6d-9d19-4dd0-ba23-18aeb2e6e6b8
Yuksel, B.
43b1edf1-50e1-45af-ac42-324d9a1bfed2
Sampson, A. P.
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
Greenough, A.
75a1b8a8-773e-49bd-b038-f9e7bfae1b2a
Price, J. F.
bd1568a3-65bb-48a4-b197-d89be55301e4
Cook, A. J.
44a62c6d-9d19-4dd0-ba23-18aeb2e6e6b8
Yuksel, B.
43b1edf1-50e1-45af-ac42-324d9a1bfed2
Sampson, A. P.
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
Greenough, A.
75a1b8a8-773e-49bd-b038-f9e7bfae1b2a
Price, J. F.
bd1568a3-65bb-48a4-b197-d89be55301e4

Cook, A. J., Yuksel, B., Sampson, A. P., Greenough, A. and Price, J. F. (1996) Cysteinyl leukotriene involvement in chronic lung disease in premature infants. European Respiratory Journal, 9 (9), 1907-1912. (doi:10.1183/09031936.96.09091907).

Record type: Article

Abstract

The pathopbysiology of chronic lung disease (CLD) in premature infants who require mechanical ventilation and prolonged oxygen supplementation has been well-described but the underlying mechanisms are not understood. Our aim was to test the hypothesis that excess cysteinyl leukotriene (LT) production was a contributing factor in CLD. We compared LT production and lung function, at 7 months of age, in nine premature infants with CLD and in eight control infants without CLD. None of the control infants developed any neonatal respiratory problems, but two subsequently required bronchodilator therapy. Respiratory function was assessed by the measurement of thoracic gas volume (TGV), airways resistance (Raw) and functional residual capacity (FRC). Total cysteinyl LT production was quantified by measurement of leukotriene E4 (LTE4) in a spot urine sample. Although all patients were asymptomatic at follow-up, there was evidence of significant lung function abnormalities in infants with CLD. The CLD infants had significantly elevated TGV, Raw and FRC values reflecting airway obstruction when compared to the controls. Urinary LTE4 levels were significantly higher in the CLD infants when compared to the controls (geometric mean: 741 and 337 pmol · mmol-1 creatinine, respectively). There was no direct correlation between urinary LTE4 levels in the CLD group and TGV, Raw or FRC values. Although this study is small and a direct correlation between lung function and urinary leukotriene E4 was not demonstrated, pathological lung function and an enhanced urinary leukotriene E4 production in infants with chronic lung disease would tend to suggest that the cysteinyl leukotrienes were involved in the sequelae of this disease.

This record has no associated files available for download.

More information

Published date: 1996
Additional Information: Copyright: Copyright 2018 Elsevier B.V., All rights reserved.
Keywords: Chronic lung disease, Lung function, Prematurity, Urinary leukotriene E

Identifiers

Local EPrints ID: 455208
URI: http://eprints.soton.ac.uk/id/eprint/455208
ISSN: 0903-1936
PURE UUID: e81a2fc1-a84e-4760-aed9-c943a80f80c2
ORCID for A. P. Sampson: ORCID iD orcid.org/0009-0008-9653-8935

Catalogue record

Date deposited: 15 Mar 2022 17:33
Last modified: 17 Mar 2024 02:43

Export record

Altmetrics

Contributors

Author: A. J. Cook
Author: B. Yuksel
Author: A. P. Sampson ORCID iD
Author: A. Greenough
Author: J. F. Price

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×